Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain radiation and memory: new study maps hidden risks

NCT ID NCT04390906

First seen May 27, 2026 · Last updated Jun 24, 2026 · Updated 1 time

Summary

This study follows 75 adults with benign or slow-growing brain tumors who are receiving partial brain radiation. Researchers will use memory tests and MRI scans before treatment and at 6 and 12 months after to see how radiation affects thinking and memory. The goal is to identify which brain structures are most vulnerable to radiation damage, so future treatments can be designed to protect them.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • James P. Wilmot Cancer Center at University of Rochester Medical Center

    Rochester, New York, 14642, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

partial brain radiation therapy

What this could lead to

If successful, this study could help doctors design safer radiation plans that spare key brain areas and reduce memory problems after treatment.

What could go wrong

This is a small pilot study, not a treatment trial. It only observes changes and cannot prove that any new approach improves outcomes. Results may not apply to all brain tumor patients.

Conditions

The condition(s) this trial relates to.

brain cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.